Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]MC225-PET for P-gp Function in Neurodegenerative Disease
NCT05853471Phase 2Unknown
- Sponsor
- University Medical Center Groningen
- Start
- Feb 2022
- Primary completion
- Jan 2024
- Countries
- 1
01
Overview
Phase 2, open-label trial (3 arms), sponsored by University Medical Center Groningen. Primary endpoint: P-glycoprotein function at 60 minutes. Status: unknown.
Beyond the preview
Go deeper on NCT05853471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05853471.